产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20635 | ERAS-801 ( JGK-068S ) | 2490431-16-6 | ≧98.0% |  |
| ERAS-801 ( JGK-068S ) 是一种有效的 EGFR 抑制剂。 | ||||
| 20636 | Edecesertib | 2408839-73-4 | 98% Min. |  |
| Edecesertib is a serine/threonine kinase inhibitor and anti-inflammatory. Edecesertib | ||||
| 20607 | Ezurpimtrostat HCl | 1914148-73-4 | 98% Min. |  |
| Ezurpimtrostat is a palmitoyl protein thioesterase 1 (PPT-1) inhibitor. | ||||
| 20603 | EN460 | 496807-64-8 | 98% Min. |  |
| EN460 is an endoplasmic reticulum oxidoreductase (ERO1) inhibitor. EN460 showed a dos | ||||
| 20546 | (E)-4-吗啉酮-2-烯酸盐酸盐 | 1419865-05-6 | 98% Min. | -4-Morpholinobut-2-enoic_acid_hydrochloride_1419865-05-6.png) |
| 20523 | 1-乙基-1H-吡唑-4-甲醛 | 304903-10-4 | 98% Min. |  |
| 20480 | ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate | 2359650-50-1 | ≧96.0% |  |
| 20449 | Ervogastat (PF-06865571) | 2186700-33-2 | ≧98.0% | _2186700-33-2.png) |
| Ervogastat (PF-06865571) 是一种具有全身作用的二酰基甘油酰基转移酶 | ||||
| 20447 | ELQ300 | 1354745-52-0 | 98% Min. |  |
| ELQ300 is a novel inhibitor of the mitochondrial cytochrome bc1 complex (complex III | ||||
| 20443 | Etrumadenant | 2239273- 34-6 | 98% Min. |  |
| Etrumadenant, also known as AB928, is a dual antagonist of the A2aR and A2bR adenosin | ||||
| 20436 | E6446 | 1219925-73-1 | 98% Min. |  |
| E6446 is a TLR inhibitor. E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E | ||||
| 171455 | Etrumadenant | 2239273-34-6 | 98% Min. |  |
| Etrumadenant, also known as AB928, is a dual antagonist of the A2aR and A2bR adenosin | ||||
| 171652 | EZM0414 | 2411748-50-8 | ≧98.0% |  |
| EZM0414 是一种有效的、选择性的、具有口服生物利用度的 SETD2 抑制 | ||||
| 20390 | 4,6-二羟基哒嗪-3-甲酸乙酯 | 1352925-63-3 | 98% Min. |  |
| G20384 | 5-(Ethoxycarbonyl)-2-formyl-4-methyl-1H-pyrrole-3-propanoic Acid Methyl Ester | 54278-05-6 | 98% Min. | -2-formyl-4-methyl-1H-pyrrole-3-propanoic_Acid_Methyl_Ester_54278-05-6.png) |
| 20366 | 3-甲酰基-4-羟基苯甲酸乙酯 | 82304-99-2 | 98% Min. |  |
| 20365 | ethyl 3-bromo-4-ethoxy-5-formylbenzoate | 2701520-23-0 | 98% Min. |  |
| 20360 | 乙基 4-羟基-6-甲基吡唑并[1,5-A]吡嗪-2-甲酸基酯 | 1443978-76-4 | 98% Min. |  |
| 20359 | 4-氯-6-甲基吡唑并[1,5-A]吡嗪-2-甲酸乙酯 | 1449598-75-7 | 98% Min. |  |
| 20358 | 乙基 4,6-二甲基吡唑并[1,5-A]吡嗪-2-甲酸基酯 | 1449598-76-8 | 98% Min. |  |
| 20354 | Eribulin Mesylate | 441045-17-6 | 98% Min. |  |
| Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Er | ||||
| 20327 | 2-氧代-4-乙氧基-1,2-二氢吡啶-3-甲酸乙酯 | 1174046-84-4 | 96% Min. |  |
| 20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% |  |
| Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
| 20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% |  |
| Elinzanetant，以前称为 NT-814 (45)，是一种双重 NK1,3R 拮抗剂，因此有 | ||||
| 16122809 | 依拉司群 | 722533-56-4 | ≧98.0% |  |
| 依拉司群(Elacestrant), also known as RAD1901, is an orally available, selective e | ||||
| 21240 | E6446 | 1219925-73-1 | 98% Min. |  |
| 61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | _1884461-72-6.png) |
| Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o | ||||
| 2073104 | Enarodustat ( JTZ-951 ) | 1262132-81-9 | 98% Min. | _1262132-81-9.png) |
| Enarodustat ( JTZ-951 ) is an orally-active HIF-PH inhibitor with an EC50 of 0.22 Μm | ||||
| 2071554 | Empesertib | 1443763-60-7 | 98% Min. |  |
| Empesertib, also known as BAY1161909, is an orally bioavailable, selective inhibitor | ||||
| 2071537 | EIDD-1931 | 3258-02-4 | 98% Min. |  |
| EIDD-1931 is a promising COVID-19 inhibitor. EIDD-1931 has broad spectrum antiviral a | ||||